3Forrest JA,Finlagson ND,Adijepon-Yamoak KK,et al. Antipyrine,par acetamol,and lignocaine elimination in chronic liver disease[J]. Br Med J,1977 ,28(6073):1384-1387.
4Gremse DA,A-Kader HH,Schroerer TJ,et al. Assessment of lidocaine metabolite formation as a quantitative liver function test in children[J]. Hep atology,1990,12(3):565-568.
5Klinker H,Joeres R,Bomhard M,et al. Lidocaine elimination and MEGX formation after oral lidocaine administration-a practicable test for as sessment of quantitative liver function[J]. Z Gastroenterol,1993,31(Suppl 2): 52-55.
6Oellerich M,Raude E,Burdelski M,et al. Monoethylglycinexy lidide formation kinetics: a novel approach to assessment of liver function[J] . J Clin Chem Clin Biochem,1987,25(12):845-853.
7Chen Y,Potter JM. Fluorescence polarization immunoassay and HPLC a ssays compared for measuring monoethylglicinexylidide in liver-transplant patie nts[J]. Clin Chem,1992,38:2426-2430.
8Leclercq I,Saliez A,Wallemacq PE,et al. The monoethylglyci nexylid-ide test does not correctly evaluate lidocaine metabolism after ische mic liver injury in the rats[J]. Hepatology,1997,26:1182-1188.
9Laroche N,Leneveu A,Roux A,et al. Capillary gas chromatog raphic method for the measurement of small Concentrations of monoethylglycinexyl idide and lidocaine in plasma[J]. J of Chromatogr Biomed Sci Appl,1998,716(1- 2):375-381.
10Streit F,Niedmann PD,Shipkova M,et al. Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of mo noethylglycinexylidide[J]. Clin Chem,2001,47(10):1853-1856.
